Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Law Firms
Life Sciences
High-Tech
Competitor Tech Research
Design Risk Screening
Telecom SEP Claim Chart
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report PAN accounts for 90%+ of carbon fiber production but 50% of its cost. Explore the 2026 patent landscape for PAN, pitch, and lignin-based CFRP precursor routes.
Article | Report How MPC of active front-end rectifiers achieves superior power factor correction and THD reduction in industrial drives — evidence from 50+ peer-reviewed studies.
Article | Report PEDOT:PSS, polyaniline, and polypyrrole in flexible electronics and sensors: engineering strategies, performance data, and IP landscape for 2026.
Article | Report PD-1/PD-L1 inhibitors, somatostatin analogs, and mTOR-targeted agents in thymoma and thymic carcinoma: clinical evidence, molecular targets, and pipeline signals.
Article | Report How to reduce common-mode leakage current in transformerless PV inverters to meet IEC 62109. Topology, modulation, and control strategies reviewed.
Article | Report Explore the neonatal RDS drug pipeline: synthetic surfactant evolution, inhaled nitric oxide for PPHN, and novel PPARγ, exosome, and antioxidant lung maturation strategies.
Article | Report How phasor measurement units enable early detection of inter-area oscillations in large power grids — signal processing, source localization, and damping control.
Article | Report PEDOT:PSS, polyaniline, and polypyrrole in flexible electronics and sensors: engineering strategies, key players, and IP trends for 2026. 50+ sources analysed.
Article | Report Anti-VEGF intravitreal dosing, IGF-1 signalling, and laser adjunct approaches in the ROP drug pipeline — evidence from 1,627-eye cohorts and emerging targets.
Article | Report How to reduce flicker noise from grid-tied inverters in weak grid conditions: control strategies, impedance reshaping, PLL redesign, and filter techniques explained.
Article | Report MSC therapy, IGF-1, and TGF-β antagonism are reshaping the BPD drug pipeline. Explore the clinical evidence, patent landscape, and emerging regenerative strategies.
Article | Report How DERMS and predictive grid edge control reduce solar curtailment in high-PV networks — OPF, MPC, smart inverters and real-world validation from NREL, EPFL and more.
Article | Report Explore the RPL drug pipeline: LMWH, IVIg, tacrolimus, PRP, and hydroxychloroquine targeting thrombophilia, immune dysregulation, and uterine receptivity.
Article | Report How to reduce capacity loss from transition metal dissolution in high-voltage spinel cathodes: electrolyte engineering, crystal facet control, and single-crystal design.
Article | Report Explore the female infertility drug pipeline: FSH analogs, AMH biomarkers, kisspeptin triggers, and ovarian stimulation protocols shaping the next wave of fertility treatments.